AAAAAA

   
Results: 1-7 |
Results: 7
IMPRECISION IN COUNTING CFU-GM COLONIES AND CD34 EXPRESSING CELLS
Authors: SERKE S MEYER O ARSENIEV L WATTS M INGLESESTEVE J FRITSCH G JOHNSSEN HE MATCHAM J
Citation: S. Serke et al., IMPRECISION IN COUNTING CFU-GM COLONIES AND CD34 EXPRESSING CELLS, Bone marrow transplantation, 22, 1998, pp. 29-29
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE-III STUDY OF FILGRASTIM IN REMISSION INDUCTION AND CONSOLIDATION THERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML)
Authors: HEIL G HOELZER D SANZ MA LECHNER K YIN JAL PAPA G NOENS L SZER J GANSER A OBRIEN C MATCHAM J BARGE A
Citation: G. Heil et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE-III STUDY OF FILGRASTIM IN REMISSION INDUCTION AND CONSOLIDATION THERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML), British Journal of Haematology, 102(1), 1998, pp. 223-223
IMPRECISION OF COUNTING CFU-GM COLONIES AND CD34-EXPRESSING CELLS
Authors: SERKE S ARSENIEV L WATTS M FRITSCH G INGLESESTEVE J JOHNSEN HE LINCH D CANCELAS JA MEYER O KADAR JG HUHN D MATCHAM J
Citation: S. Serke et al., IMPRECISION OF COUNTING CFU-GM COLONIES AND CD34-EXPRESSING CELLS, Bone marrow transplantation, 20(1), 1997, pp. 57-61
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE-III STUDY OF FILGRASTIM IN REMISSION INDUCTION AND CONSOLIDATION THERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: HEIL G HOELZER D SANZ MA LECHNER K YIN JAL PAPA G NOENS L SZER J GANSER A OBRIEN C MATCHAM J
Citation: G. Heil et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE-III STUDY OF FILGRASTIM IN REMISSION INDUCTION AND CONSOLIDATION THERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA, Blood, 90(12), 1997, pp. 4710-4718
RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP
Authors: TRILLETLENOIR V GREEN JA MANEGOLD C VONPAWEL J GATZEMEIER U LEBEAU B DEPIERRE A JOHNSON P DECOSTER G MATCHAM J EWEN C
Citation: V. Trilletlenoir et al., RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP, European journal of cancer, 31A(12), 1995, pp. 2115-2116
RESULTS OF A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-III STUDY OF FILGRASTIM IN REMISSION INDUCTION AND EARLY CONSOLIDATION THERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: HEIL G HOELZER D SANZ MA LECHNER K YIN JL PAPA G NOENS L HO J OBRIEN C MATCHAM J BARGE A
Citation: G. Heil et al., RESULTS OF A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-III STUDY OF FILGRASTIM IN REMISSION INDUCTION AND EARLY CONSOLIDATION THERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA, Blood, 86(10), 1995, pp. 1053-1053
A RANDOMIZED PHASE-III STUDY OF FILGRAMSTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) IN COMPARISON WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH HODGKINS-DISEASE(HD) AND NON-HODGKINS-LYMPHOMA (NHL)
Authors: SCHMITZ N LINCH DC DREGER P BOOGAERTS MA GOLDSTONE AH FERRANT A DEMUYNCK HMS LINK H ZANDER A MATCHAM J BORKETT KM SCHWAB G
Citation: N. Schmitz et al., A RANDOMIZED PHASE-III STUDY OF FILGRAMSTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) IN COMPARISON WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH HODGKINS-DISEASE(HD) AND NON-HODGKINS-LYMPHOMA (NHL), Blood, 84(10), 1994, pp. 10000204-10000204
Risultati: 1-7 |